https://tho7377.wixsite.com/mysite
Oligomed: Oligonucleotide Therapies for Medical Applications
OLIGOMED is an EU H2020 funded ETN comprising 12 Beneficiaries, 4 Partners, and 15 early stage reserachers. OLIGOMED will develop a Next Generation...
oligonucleotide therapiesfor medicalapplications
https://tobias-lib.uni-tuebingen.de/xmlui/handle/10900/141855?show=full
Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function...
oligonucleotide therapies
https://cureheart.web.ox.ac.uk/article/bhf-discuss-antisense-oligonucleotide-aso-therapies-interview-cureheart-pi-matthiew-wood
The BHF discuss Antisense Oligonucleotide (ASO) therapies in an interview with CureHeart PI Matthew...